Press Releases Addex Therapeutics Ltd

Equities

Delayed Swiss Exchange Other stock markets 10:17:31 2024-04-29 am EDT			5-day change	1st Jan Change
0.068 ^CHF	-41.13%		-55.84%	+47.83%

03:09pm	Tech Rally Subsides as US Equity Futures Waver Pre-Bell	MT
01:57pm	Top Premarket Decliners	MT

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study	01:00am	GL
Addex to Present at the Swiss Biotech Day 2024	Apr. 19	GL
Addex to Present at the Swiss Biotech Day 2024	Apr. 19	AQ
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update	Apr. 18	GL
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update	Apr. 18	AQ
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024	Apr. 11	GL
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders	Apr. 03	GL
Addex to Present at the Bio-Europe Spring 2024 Conference	Mar. 14	GL
Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.	Jan. 31	GL
Addex to Present at the Swiss Equities Baader Conference	Jan. 09	GL
Addex to Present at the Swiss Equities Baader Conference	Jan. 09	AQ
Addex to Present at the Swiss Equities Baader Conference	Jan. 09	DJ
Addex to Present at Biotech Showcase™ 2024	Jan. 05	GL
Addex to Present at Biotech Showcase™ 2024	Jan. 05	AQ
Addex to Present at Biotech Showcase(TM) 2024	Jan. 05	DJ
Addex Shareholders Approve All Resolutions at Extraordinary General Meeting	Dec. 20	GL
Addex Shareholders Approve All Resolutions at Extraordinary General Meeting	Dec. 20	DJ
Addex Creates Treasury Shares	Dec. 14	GL
Addex Creates Treasury Shares	Dec. 14	AQ
Addex Reports Q3 2023 Financial Results and Provides Corporate Update	Nov. 29	GL

No results for this search